An interventional study of Whole-body vibration training in Knee OA, Sarcopenic Obesity and Whole Body Vibration, sponsored by Beni-Suef University. Enrolling by invitation at 1 site in Egypt. Open to participants aged 60 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-10-02.
Sponsored by Beni-Suef University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 91 studies in Osteoarthritis, Knee with a site in Egypt — 28 open to participants now, 34 under way, 1 of them phase 3. Osteoarthritis, Knee · Egypt.
Among the 91 studies in Osteoarthritis, Knee with a site in Egypt, this one is the 76th largest by planned enrollment of the 83 interventional ones that give a count, is one of 15 that started in 2026, is one of 76 with no phase, reaches primary completion later than 24 of the 33 other live ones, and was the 77th registered.
3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.
Browse Osteoarthritis, Knee studies →28 of the 91 studies in Osteoarthritis, Knee with a site in Egypt are open now. Recruiting first, the newest first:
Tanta University · Sites in Egypt
Ages 18+
National Cancer Institute, Egypt · Sites in Egypt
Ages 40+
Tanta University · Sites in Egypt
Ages 50+
Tanta University · Sites in Egypt
Ages 50+
Tanta University · Sites in Egypt
Ages 18+
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.
This study: 60 Years to 75 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
91 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 3 · Phase 3 3 · Phase 4 2
First in 2011; this study’s year is marked. 15 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 30 is below the median of 68 across 2,719 interventional studies indexed under Osteoarthritis, Knee.
Median enrollment 62 across the 83 interventional studies, 69 across the 8 observational. Of the 50 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 91 has an industry lead sponsor. The 10 most frequent:
Beni-Suef University is the lead sponsor of 350 studies on the registry; 124 are open to participants now.
Beni-Suef University has 2 studies filed under Osteoarthritis, Knee — fewer than ten, so there is no comparison to draw.
11 of the studies in Osteoarthritis, Knee with a site in Egypt that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07047040Phase 3Assiut UniversityAnalgesic Efficacy of Pre-operative Dose of Ketorolac and Gabapentin | 2027-10-30 |
| NCT07664371Tanta UniversityCryoneurolysis Versus Radiofrequency in Knee Osteoarthritis | 2026-11 |
| NCT07468734German International UniversityShock Wave Versus Traditional Physical Therapy for Adult Chronic Knee Osteoarthritis | 2026-11-30 |
| NCT07666347Tanta UniversityIntraarticular Injection of Botox and Hyaluronic Acid in Knee Osteoarthritis | 2026-12-01 |
| NCT07478861Beni-Suef UniversityWhole-body Vibration Training on the Elderly With Combined Bilateral Knee Osteoarthritis | 2027-02-15 |
Add all 11 to your calendar (.ics) → With an account.
Among the 91 studies in Osteoarthritis, Knee with a site in Egypt, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study will aim to evaluate the effects of whole-body vibration training (WBVT) on body composition, muscle strength (hand grip strength), and physical performance [gait speed (GS), 5-time chair stand test (5CST), and short physical performance battery (SPPB), pain intensity, triglycerides in older people with knee OA and sarcopenic obesity in a group of Men compared to group of females.
Both groups received the intervention 3 times a week for 12 weeks. WBVT group. Each intervention lasted 30 min, which included 5 min of warm-up, 20 min of vibration training, and 5 min of relaxation.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Elderly male patients with knee osteoarthritis associated with sarcopenic obesity
Other: Whole-body vibration training
Elderly female patients with knee osteoarthritis associated with sacropenic obesity
Other: Whole-body vibration training
Whole-body vibration therapy stimulates muscle contraction. It can increase muscle function to a level like that of classical resistance training, but with the advantage of being more convenient and safer
Physical performance
These are standardized tests used to assess lower limb strength, mobility, and overall functional ability in elderly patients it includes: 1. Gait speed (it is the rate a person can tolerate walking measured in meter per seconds (ask the person to walk at their usual comfortable pace for 10 meters; and record how many seconds it takes to complete this distance and evaluate the recorded time before and after the treatment); 2. 5-time chair stand test; t evaluates how quickly a participant can perform 5 successive sit-to-stand without using their arms (it evaluate the time taken to complete 5 repetitions, a. ≤ 12 seconds is considered normal physical performance, b. \> 15 seconds may indicate lower extremity weakness, mobility limitations, or increased fall risk, c. Unable to complete indicates significant functional impairment). All measurements will be carried out before the treatment and after the end of the treatment.
Time frame: 8 weeks
Start is estimated for Nov 2026; primary completion for Feb 2027, 3 months later.
Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 3 months is below that.
Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 2, 2026: start Mar 2026 → Nov 2026, primary completion Jun 2026 → Feb 2027 and completion Jul 2026 → Apr 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.